Search Within

Anthony Joseph Proli II

Formats
  1. Meeting Abstract (15)
  2. Journal Article (5)
  3. Research Letter (1)
Groups
  1. Department of Medicine (20)
  2. Hematologic Malignancies, Division of (20)
  3. Bone Marrow Transplant (19)
  4. Center for Hematologic Malignancies (19)
  5. Clinical Pharmacy Specialists (19)
  6. Survivorship Research (15)

More Groups

People
  1. Andrew Lin (19)
  2. Sergio Giralt (16)
  3. Valkal Bhatt (16)
  4. Miguel-Angel Perales (13)
  5. Lauren DeRespiris (10)
  6. Ann Jakubowski (9)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2020 (4)
  4. 2019 (6)
  5. 2017 (3)
  6. 2016 (4)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (11)
  2. Bone Marrow Transplantation (3)
  3. Blood (2)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. Clinical Pharmacokinetics (1)
  6. Leukemia and Lymphoma (1)

More Publications

Publishers
  1. Elsevier Inc. (13)
  2. Nature Publishing Group (3)
  3. American Society of Hematology (2)
  4. Adis International Ltd (1)
  5. Taylor & Francis Group (1)
  6. Wiley Blackwell (1)

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience
    Journal Article

    Lin, A.; Maloy, M.; Su, Y.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A.; Barker, J.; Shaffer, B.; more...
    Transplant Infectious Disease (2019)

    Fulltext@MSK | Save
  • Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Letermovir in hematopoietic cell transplantation: Beyond the label
    Meeting Abstract

    Lin, A.; Maloy, M. A.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Barker, J. N.; Shaffer, B. C.; Giralt, S. A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Outcomes of pharmacokinetically targeted busulfan-based conditioning regimen for patients with myelodysplastic syndrome and acute myelogenous leukemia undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Beyer, K.; Proli, A. J.; Zheng, J. T.; Bhatt, V.; Lin, A.; Papadopoulos, E. B.; Jakubowski, A. A.; Perales, M. A.; Castro-Malaspina, H.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Impact of busulfan exposure on transplant outcomes for patients with relapsed multiple myeloma undergoing CD34-selected allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Lin, A.; Drill, E.; Proli, A. J.; Beyer, K.; Bhatt, V.; Devlin, S. M.; Koehne, G.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Outpatient foscarnet administration incorporating home infusions is feasible greatly enhancing the care of hematopoietic stem cell transplant recipients
    Meeting Abstract

    Beyer, K.; Abboud, M.; Hambright, K.; Lin, A.; Proli, A. J.; Bhatt, V.; Castillo, C.; Ponce, D. M.; Barker, J. N.; Perales, M. A.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Outcomes of pharmacokinetically targeted busulfan-based conditioning regimen for patients with myelodysplastic syndrome and acute myelogenous leukemia undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Beyer, K.; Proli, A.; Zheng, J.; Devlin, S.; Bhatt, V.; Lin, A.; Papadopoulos, E. B.; Jakubowski, A. A.; Perales, M.; Giralt, S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Analysis of cyclosporine A levels supports new dosing guidelines in adult double-unit cord blood transplant recipients to optimize immunosuppression early post-transplant
    Journal Article

    Bhatt, V.; Lin, A.; Beyer, K.; Proli, A.; Yoo, Y.; Ponce, D.; Barker, J.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Analysis of cyclosporine-a (CSA) levels supports new dosing guidelines in adult double unit cord blood transplant (dCBT) recipients to optimize immunosuppression early post-transplant
    Meeting Abstract

    Bhatt, V.; Lin, A.; Beyer, K.; Proli, A. J.; Yoo, Y.; Lauer, E.; Giralt, S. A.; Ponce, D. M.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Impact of busulfan exposure on transplant outcomes for patients with advanced myelodysplastic syndrome undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Proli, A. J.; Tamari, R.; Zheng, J.; Jakubowski, A. A.; Papadopoulos, E.; Ponce, D. M.; Devlin, S. M.; Sauter, C. S.; Perales, M. A.; Young, J. W.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save